TR199501326A2 - Otoimmün hastaliklarin immünoterapilerinde kullanilmak üzere otoantijenden üretilen yeni peptidler. - Google Patents

Otoimmün hastaliklarin immünoterapilerinde kullanilmak üzere otoantijenden üretilen yeni peptidler.

Info

Publication number
TR199501326A2
TR199501326A2 TR95/01326A TR9501326A TR199501326A2 TR 199501326 A2 TR199501326 A2 TR 199501326A2 TR 95/01326 A TR95/01326 A TR 95/01326A TR 9501326 A TR9501326 A TR 9501326A TR 199501326 A2 TR199501326 A2 TR 199501326A2
Authority
TR
Turkey
Prior art keywords
autoantigen
peptides
seq
pct
autoimmune diseases
Prior art date
Application number
TR95/01326A
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Gijbertus Franciscu Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of TR199501326A2 publication Critical patent/TR199501326A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TR95/01326A 1994-10-27 1995-10-27 Otoimmün hastaliklarin immünoterapilerinde kullanilmak üzere otoantijenden üretilen yeni peptidler. TR199501326A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203128 1994-10-27
EP95200886 1995-04-07

Publications (1)

Publication Number Publication Date
TR199501326A2 true TR199501326A2 (tr) 1996-06-21

Family

ID=26136688

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01326A TR199501326A2 (tr) 1994-10-27 1995-10-27 Otoimmün hastaliklarin immünoterapilerinde kullanilmak üzere otoantijenden üretilen yeni peptidler.

Country Status (23)

Country Link
US (1) US5736507A (tr)
EP (1) EP0733065B1 (tr)
JP (1) JP3755894B2 (tr)
KR (1) KR100485979B1 (tr)
CN (1) CN1161379C (tr)
AT (1) ATE177756T1 (tr)
AU (1) AU696827B2 (tr)
BR (1) BR9506377A (tr)
CA (1) CA2173874A1 (tr)
DE (1) DE69508380T2 (tr)
DK (1) DK0733065T3 (tr)
ES (1) ES2130672T3 (tr)
FI (1) FI118472B (tr)
GR (1) GR3030296T3 (tr)
HU (1) HU218027B (tr)
IL (1) IL115744A (tr)
MX (1) MX9602495A (tr)
NO (1) NO316703B1 (tr)
NZ (1) NZ295659A (tr)
PL (1) PL183761B1 (tr)
RU (1) RU2178797C2 (tr)
TR (1) TR199501326A2 (tr)
WO (1) WO1996013517A1 (tr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
TW575583B (en) 1996-04-24 2004-02-11 Akzo Nobel Nv Novel peptides suitable for use in antigen specific immunosuppressive therapy
US6881824B1 (en) 1996-04-24 2005-04-19 Akzo Nobel N.V. Peptides suitable for use in antigen specific immunosuppressive therapy
BR9711499A (pt) * 1996-09-18 1999-08-24 Zetesis Spa Uso de prote¡nas como agentes contra doen-as auto-imunes
EP0947524A1 (en) * 1998-03-30 1999-10-06 Upither B.V. Novel peptides for the treatment of autoimmune diseases
ID27998A (id) 1998-07-23 2001-05-03 Akzo Nobel Nv Peptida baru untuk penggunaan dalam imunoterapi pada penyakit atau atoimun
EP1100526A2 (en) * 1998-07-23 2001-05-23 Akzo Nobel N.V. USE OF HC gp-39 IN IMMUNE DISEASES
WO2000033833A1 (en) * 1998-12-09 2000-06-15 Yeda Research And Development Co. Ltd. Palladium-substituted bacteriochlorophyll derivatives and use thereof
MXPA02003520A (es) * 1999-10-18 2002-08-20 Akzo Nobel Nv Imitaciones de peptido y peptidos modificados para utilizarse en inmunoterapia.
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US7214373B2 (en) * 2001-07-24 2007-05-08 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
US20050214297A1 (en) * 2004-02-25 2005-09-29 Medimmune, Inc. Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
EP1928496A4 (en) * 2005-08-31 2011-01-05 Medimmune Inc C / CLP ANTAGONISTS AND METHOD OF USE
RU2302872C9 (ru) * 2006-06-22 2008-12-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, нормализующее функции хрящевой ткани, и способ его получения
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
EA023303B1 (ru) 2007-08-15 2016-05-31 Сиркейшиа Лимитед Пептидная композиция для формирования толерантности к клещам домашней пыли и ее применение
EP2331124A1 (en) * 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
ES2378870T5 (es) 2008-08-15 2016-02-03 Circassia Limited Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía
ES2532759T3 (es) 2009-02-05 2015-03-31 Circassia Limited Péptidos de plantas herbáceas para vacunas
WO2011051346A1 (en) * 2009-10-27 2011-05-05 Erytech Pharma Composition to induce specific immune tolerance
WO2017041051A1 (en) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
RU2770492C2 (ru) 2016-05-03 2022-04-18 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биологических молекул для индуцирования толерантности

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
GB9125024D0 (en) * 1991-11-25 1992-01-22 Kirby Julian Rheumatoid arthritus treatment
AU679439B2 (en) * 1992-02-10 1997-07-03 Duke University Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens
EP0666867A4 (en) * 1992-09-14 1997-08-27 Brigham & Womens Hospital REAGENTS AND METHODS FOR TREATING RHUMATOID ARTHRITIS.
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices

Also Published As

Publication number Publication date
WO1996013517A1 (en) 1996-05-09
BR9506377A (pt) 1997-09-16
HU218027B (hu) 2000-05-28
NO962695L (no) 1996-06-26
JP3755894B2 (ja) 2006-03-15
US5736507A (en) 1998-04-07
NO962695D0 (no) 1996-06-26
ES2130672T3 (es) 1999-07-01
HUT74847A (en) 1997-02-28
IL115744A0 (en) 1996-01-19
CN1161379C (zh) 2004-08-11
AU696827B2 (en) 1998-09-17
EP0733065B1 (en) 1999-03-17
NZ295659A (en) 1998-02-26
CA2173874A1 (en) 1996-05-09
DE69508380T2 (de) 1999-09-09
NO316703B1 (no) 2004-04-13
MX9602495A (es) 1997-05-31
ATE177756T1 (de) 1999-04-15
HU9601401D0 (en) 1996-07-29
RU2178797C2 (ru) 2002-01-27
AU3925295A (en) 1996-05-23
GR3030296T3 (en) 1999-09-30
EP0733065A1 (en) 1996-09-25
JPH09507861A (ja) 1997-08-12
IL115744A (en) 2000-07-16
FI962619A0 (fi) 1996-06-25
KR960705848A (ko) 1996-11-08
DE69508380D1 (de) 1999-04-22
HK1002012A1 (en) 1998-07-24
FI962619L (fi) 1996-06-25
KR100485979B1 (ko) 2006-01-27
PL315198A1 (en) 1996-10-14
PL183761B1 (pl) 2002-07-31
CN1168677A (zh) 1997-12-24
FI118472B (fi) 2007-11-30
DK0733065T3 (da) 1999-10-11

Similar Documents

Publication Publication Date Title
IL115744A0 (en) Peptides derived from the autoantigen and pharmaceutical compositions containing them
TR199802082T2 (tr) Otoantigen ve otoimün hastaliklarin imünoterapisinde kullanilmak için otoantigen yapisal olarak iliskili proteinler.
Ugrinovic et al. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis
Taneja et al. HLA class II transgenic mice as models of human diseases
CY1109837T1 (el) Διαγνωστικο και θεραπευτικο επιτοπιο
NO962426L (no) Spermieantigen som tilsvarer et spermie zonabindende protein autoantigenepitop
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
DE69433115D1 (de) Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien
Choudhury et al. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool
ATE185151T1 (de) Neue peptide zur verwendung bei behandlung von durch t-zellen vermittelter knorpelzerstörungin autoimmunkrankheiten
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
Elves Immunology of cartilage
Myers et al. Immunogenicity of recombinant type IX collagen in murine collagen‐induced arthritis
Buus et al. The Interaction between MHC Class II Molecules and Immunogenic Peptides
Bach GAD Peptide VaccinesforT1DM: Not Just a Blueprint?
Schwarzfischer et al. The HLA system Red cell antigens and their molecular basis Monoclonal antibodies in blood group serology Serum protein systems Biostatistics and computerisation
Nagel Out-of-Date Viruses
Dai Parameters influencing generation of cryptic pathogenic T-cell epitopes in thyroglobulin
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน